Come up with a name for your new list and we'll add to it:
Histogenics raised a round of funding on January 13, 2006. Investors include
Boston Millennia Partners.
Histogenics is a regenerative medicine company that combines cell therapy and tissue engineering technologies to develop products for tissue repair and regeneration. Histogenics' flagship product…